Cargando…
Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 Suppression
Nonalcoholic fatty liver disease (NAFLD), which has a wide global distribution, includes different stages ranging from simple steatosis to nonalcoholic steatohepatitis, advanced fibrosis, and liver cirrhosis according to the degree of severity. Chronic low‐grade inflammation, insulin resistance, and...
Autores principales: | Ye, Ping, Liu, Jijun, Xu, Wuping, Liu, Denghai, Ding, Xiangchao, Le, Sheng, Zhang, Hao, Chen, Shanshan, Chen, Manhua, Xia, Jiahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594223/ https://www.ncbi.nlm.nih.gov/pubmed/30582764 http://dx.doi.org/10.1002/hep.30485 |
Ejemplares similares
-
Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression
por: Ye, Ping, et al.
Publicado: (2018) -
Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
por: Zhao, Jing, et al.
Publicado: (2021) -
Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1
por: Jiang, Lang, et al.
Publicado: (2021) -
A Disintegrin and Metalloprotease‐22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway
por: Ren, Lingyun, et al.
Publicado: (2018) -
Dual-specificity MAP kinase phosphatases in health and disease()
por: Seternes, Ole-Morten, et al.
Publicado: (2019)